drugset / Trial / NCT05192369
A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers
RandomizedCrossoverSingle-blindOther
Summary
This is a four-arm, randomized, crossover, placebo and active controlled study to evaluate of the effect of therapeutic and supratherapeutic doses of CTP-543 on the QT/QTc intervals in healthy volunteers
Timeline
- Start
- 2022-01-04
- Primary completion
- 2022-01-28
- Completion
- 2022-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-543 | Unknown | 12 mg | Oral |
| Subject | CTP-543 | Unknown | 48 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.